Table 3.

Possible sequences for a double cross‐over design.

	Period
Sequence	1	2	3	4
I	Placebo	Active	Placebo	Active
II	Active	Placebo	Active	Placebo
III	Placebo	Active	Active	Placebo
IV	Active	Placebo	Placebo	Active